Skip to content
Search

Latest Stories

Women can visit community pharmacies for advice and treatment for uncomplicated UTIs

Women can visit community pharmacies for advice and treatment for uncomplicated UTIs

Over 3,500 women in Northern Ireland made use of the Pharmacy UTI service between March 2022 and April 2023   

Thanks to the Pharmacy First service, women in the UK can now be assessed and treated for uncomplicated Urinary Tract Infections (UTIs) much sooner by local pharmacists without having to wait for a GP appointment.


In Northern Ireland, more than 400 community pharmacies are now providing the UTI management service, which is available for women aged 16 to 64, according to the Department of Health NI.

In a statement released on Tuesday (5 December), the department ensured the public that all community pharmacists providing this service are qualified healthcare professionals with the training and ability to test and treat UTIs.

The participating community pharmacies will offer a confidential consultation in a private area where patients can discuss their symptoms with the pharmacist, who may test the patient’s urine to help determine if a UTI is present.

Self-care advice may be only needed in some UTI cases, but the community pharmacist can also supply the patient with medicines to relieve pain and if appropriate, an antibiotic, when necessary.

All women with urinary tract infections (UTI) visiting participating community pharmacies will be advised what to do if their symptoms worsen or do not resolve, the department added.

“Urinary Tract Infections can be extremely uncomfortable and it’s thought that up to 50 per cent of women will experience one during their lifetime,” said Joe Brogan, Assistant Director, Pharmacy and Medicines Management, Department of Health.

Not only the Pharmacy First UTI service does away with the need for a GP appointment, but women can be assessed and treated much sooner as “community pharmacies are more likely to be open after normal working hours, at weekends and bank holidays,” he added.

Be aware of UTI symptoms

Women are advised to watch out for symptoms of a UTI that include: burning or stinging sensation on passing urine, needing to pass urine frequently or urgently, cloudy urine, and passing excessive or large quantities of urine.

The acceptance of the UTI management service has increased significantly in Northern Ireland, following the positive evaluation of a pilot that involved around 60 pharmacies since July 2021.

Stephen Toland, Pharmacist at Murphy’s Pharmacy, Derry who has been providing this service since 2021 said: “The feedback from patients has been overwhelmingly positive. They’re really happy that they are able to get same day advice and treatment from a health professional all close to home, for a condition that can be very distressing.”

Over 3,500 women in the country benefited the pilot service between March 2022 and April 2023.  Following assessment, more than 85 per cent of these women were diagnosed with a UTI and received appropriate advice and treatment from the pharmacist.

During this period, more than 5 per cent of patients were referred to their GP or Out of Hours service.

Patients do not need to take an appointment for the Pharmacy First UTI service, they can simply request a consultation with a pharmacist of the community pharmacists providing this service.

However, Pharmacy First for everyday health conditions is available at all community pharmacies in Northern Ireland, the health department informed.

More For You

Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less